Oh there is. He is stock in the parent company that makes the drug the FDA approved yesterday as a treatment for #covid https://t.co/KoRho5Ryqa

— Barbara Malmet (@B52Malmet) October 23, 2020

Read an open letter from our Chief Medical Officer about today's @US_FDA approval of our antiviral treatment for COVID-19. https://t.co/JAyK3zJGD7

— Gilead Sciences (@GileadSciences) October 22, 2020

Can't believe this news. Biggest mockery of science, ethics and justice. Brazen ignorance of @WHO
Data from #SolidarityTrial. Unequal treatment to #HydroxyChloroquine
where even EUA revoked. World needs explanation.https://t.co/1cE6UkKIj8

— Dr Dhananjay Bakhle (@BakhleD) October 23, 2020

Dr Reddy's, Cipla, Cadila, Jubilant Life from listed space....hetero and mylan in unlisted

Remdesivir: Coronavirus treatment from Gilead approved by FDA https://t.co/NxZJmdLGj8

— Darshan Mehta (@darshanvmehta1) October 23, 2020

Remdesivir: Coronavirus treatment from Gilead approved by FDA

おお、レムデシビルがFDAから正式承認。

トランプは仮病だったとか言ってる人達はGileadの人達にすごく失礼な事をしているという自覚は...ないんだろうな。 https://t.co/fTVR4UaTr7

— Masayoshi Nakamura (@masayang) October 22, 2020

NEW: FDA approves #remdesivir as a treatment for #covid19. It had received emergency use authorization in May which allowed doctors to give it to hospitalised patients.

This comes despite WHO's Solidarity Trial finding the drug had 'little or no effect.'https://t.co/Mz4Z4ucCrl

— Julianna Tatelbaum (@CNBCJulianna) October 22, 2020

BIG NEWS:

Remdesivir: Coronavirus treatment from Gilead approved by FDA https://t.co/xkovalkEGZ

— Sriram (@SriramMadras) October 22, 2020

GileadのレムデシビルがFDAに正式承認され、アメリカ初の承認コロナ治療薬に。今までは緊急利用のみ承認されていたが、今後は入院レベルで適応となる。レムデシビルは静脈注射だが、Gileadは吸入用も開発中とのこと。肝臓に影響がある薬のため、錠剤の開発はないそう。https://t.co/CkqK6w8YXy

— 今村咲 (@saki_imamura) October 22, 2020

Today, under @realDonaldTrump’s leadership, @US_FDA has approved the first treatment for the Chinese virus.https://t.co/wAg5Neocxx

— Marsha Blackburn (@VoteMarsha) October 23, 2020

Today, the first antiviral drug for the treatment of #COVID19 patients was approved by @US_FDA. Years of investment from biopharmaceutical companies, countless setbacks and endless researcher perseverance brought us to this moment. https://t.co/vkTfX34uWN

— Stephen J. Ubl (@steveubl) October 22, 2020